U.S. pharma facilities soar in value amid Trump tariff threats 조선일보Permira seeks $4bn for sale of contract drugmaker Cambrex Financial TimesPermira looks to launch $4B sale of CDMO Cambrex: FT Fierce PharmaPermira targets $4bn Cambrex exit Private Equity WirePermira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports TradingView
